Trials / Sponsors / Sheng-Li Xue, MD
Sheng-Li Xue, MD
Academic / Other · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Venetoclax Combined With Azactidine in the Treatment of ALAL Acute Leukemia of Ambiguous Lineage | Phase 2 | 2023-07-01 |
| Recruiting | Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL ALL, MRD-positive, Hematopoietic Stem Cell Transplantation | Phase 2 | 2022-08-01 |